← Open Payments lookup

TODD AUGUSTUS: Open Payments

NPI 1912168238 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,524 in 14 payments from 7 companies in 2025. Trend: 2023 $248 · 2024 $1,299 · 2025 $1,524

Food & beverage: $1,524
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.3$306
Vanda Pharmaceuticals Inc.3$262
E.R. Squibb & Sons, L.L.C.2$247
Otsuka America Pharmaceutical, Inc.2$241
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$230
Alkermes, Inc.1$120
Axsome Therapeutics, Inc.1$119

Products named: INGREZZA, FANAPT, COBENFY, CAPLYTA, REXULTI, ARISTADA, ABILIFY MAINTENA, Auvelity.

Industry payments across DC — which companies pay providers there.